The Groundbreaking Discovery at USP: Neurons Linking Breathing to Blood Pressure Control

Researchers at the University of São Paulo (Universidade de São Paulo, USP) have made a pivotal advancement in understanding hypertension by identifying specific neurons that connect respiratory patterns to cardiovascular regulation. This finding sheds light on why some patients experience persistent high blood pressure despite medication, opening doors to novel therapies rooted in neuroscience.

The study, centered at USP's Biomedical Sciences Institute (Instituto de Ciências Biomédicas, ICB-USP) and the Ribeirão Preto Medical School (Faculdade de Medicina de Ribeirão Preto, FMRP-USP), reveals how alterations in breathing—particularly forceful exhalations—influence blood vessel constriction via the sympathetic nervous system. Led by Professor Davi José de Almeida Moraes, the team demonstrated that neurons in the lateral parafacial region (pFL), located in the brainstem's medulla oblongata, play a dual role: driving active exhalation while modulating sympathetic outflow to elevate blood pressure.

Understanding the Lateral Parafacial Region: A Key Brainstem Hub

The pFL region resides at the junction where the brain meets the spinal cord, traditionally known for orchestrating active expiration during high-demand breathing, such as exercise or stress. USP's investigation expanded this view, showing these neurons also interface with cardiovascular centers. When activated, pFL neurons synchronize exhalation with sympathetic bursts, narrowing blood vessels and spiking arterial pressure—a normal adaptation gone awry in pathology.

In everyday physiology, quiet breathing suffices without pFL involvement, but intense conditions recruit it. The USP team posits that chronic overactivation, as in obstructive sleep apnea's intermittent hypoxia, sustains hypertension by perpetuating these oscillations.

Innovative Methods Employed by USP Neuroscientists

Employing cutting-edge optogenetics and pharmacogenetics in rodent models, the researchers precisely manipulated pFL neurons. Optogenetic activation—using light-sensitive proteins introduced via viral vectors—triggered robust exhalation and concurrent blood pressure rises, confirming the causal link. Conversely, sustained inhibition normalized pressure in hypertensive rats modeled with chronic intermittent hypoxia.

Thiago dos Santos Moreira, a prominent USP physiologist specializing in respiratory-cardiovascular integration, contributed foundational insights into brainstem mechanisms, complementing Moraes' work. These techniques, honed at USP labs, exemplify Brazil's prowess in advanced neuroscience.

Core Findings: Expiratory Oscillations as Hypertension Drivers

Key results showed pFL neuron stimulation evokes expiratory efforts coupled with sympathetic surges, elevating mean arterial pressure. In disease models, this hyperactivity persists, explaining neurogenic hypertension—where central nervous dysfunction overrides peripheral controls. About 40% of global hypertension cases resist standard drugs; USP's model links this to pFL-driven breathing anomalies.

Professor Moraes noted, "It had never been demonstrated that neurons generating expiratory activity communicated with those controlling blood vessel diameter to impact blood pressure." This integration positions pFL as a nexus for respiratory-cardiovascular crosstalk.

Neurogenic Hypertension and Sleep Apnea: Brazil's Twin Epidemics

In Brazil, hypertension affects nearly 30% of adults—over 55 million people—with control rates lagging at 38%. Obstructive sleep apnea, prevalent in 20-30% of hypertensives, exacerbates via intermittent hypoxia, mirroring USP's models. USP's findings suggest apnea-induced pFL overdrive sustains sympathetic hyperactivity, a cycle unbroken by antihypertensives.

São Paulo studies show 26.3% prevalence among adults over 20, underscoring urgency. Targeting pFL could revolutionize management for resistant cases.

Photo by Wolfgang Hasselmann on Unsplash

Therapeutic Horizons: Targeting pFL Neurons for Precision Medicine

USP proposes ATP receptor blockade in oxygen-sensing pathways, building on carotid body research. Prior USP work showed such inhibition curbs sympathetic drive; now, pFL specificity refines this. Future pharmacologics or neuromodulation devices could selectively dampen pFL without impairing breathing.Read the full Circulation Research paper.

This aligns with Brazil's SUS (Sistema Único de Saúde) push for innovative therapies amid rising non-communicable diseases.

USP's Legacy in Respiratory and Cardiovascular Neuroscience

USP, Latin America's top-ranked university per QS 2026, leads Brazil's biomedical research. Labs under Moraes and Moreira have pioneered brainstem mapping, with over 200 publications on chemoreception and autonomic control. FMRP-USP's interdisciplinary hubs foster such breakthroughs, training PhDs who staff Brazil's research ecosystem.

Funding from FAPESP and CNPq underscores USP's role, producing 25% of Brazil's high-impact med papers.

Brazil's Hypertension Burden: Statistics and Societal Impact

2026 Vigitel data projects 29% adult prevalence, with urban São Paulo at 26%. Non-adherence hits 60%, per USP multicentric studies, fueling 200,000 annual CVD deaths. Economic toll: R$50 billion yearly. Vulnerable groups—low-income, obese—bear 70% burden, demanding targeted interventions.

• Prevalence: 55M adults affected
• Control rate: 38% (21M controlled)
• Risk factors: 71% diagnosed, but lifestyle gaps persist

Stakeholder Perspectives: From Clinicians to Policymakers

Brazilian Society of Hypertension praises USP's work for addressing resistant cases. Clinicians note apnea-hypertension overlap in SUS patients; USP trials could integrate with telehealth. Policymakers eye national strategies, linking to Viva Mais Brasil's R$340M health promo.SUS hypertension initiatives.

Patient advocates highlight breathing therapies' accessibility.

Global Collaborations and USP's International Reach

Partnership with Auckland's Cardiac Research Center exemplifies USP's global ties, yielding co-authored Circulation Research paper. Such alliances amplify Brazil's voice in neuroscience, with USP hosting IBRO symposia.

Future: Clinical translation via USP-Auckland trials.

Photo by Bioscience Image Library by Fayette Reynolds on Unsplash

Future Outlook: Transforming Hypertension Care in Brazil

USP's pFL discovery heralds era of neuron-specific therapies, potentially halving resistant hypertension via drugs targeting ATP pathways. Integrated with Brazil's med schools, it promises training pipelines for neuro-cardio specialists. Challenges: Scaling optogenetics to humans, funding trials.

Optimism prevails: USP innovations position Brazil forefront in precision med.News-Medical coverage.